The Conafay Group
Brian Tse has a diverse work experience that spans over a decade. Brian currently works as the Vice President for The Conafay Group since September 2021. Brian served at the U.S. Department of Health and Human Services (HHS) for almost a decade, holding various positions, including Health Scientist, Chief of Staff (Interim), and Program Analyst. Brian worked as an AAAS Science & Technology Policy Fellow within the U.S. Dept. of Health & Human Services at the Division of CBRN Countermeasures, Biomedical Advanced Research & Development Authority (BARDA), and Office of the Assistant Secretary for Preparedness & Response (ASPR). Brian also worked as a freelance Science Writer, Editor & Communications consultant, and as a Christine Mirzayan Science & Technology Policy Fellow at The National Academies of Sciences, Engineering, and Medicine. Earlier in their career, they worked as a Preceptor (Teaching Faculty) at Harvard University.
Brian Tse earned a high school diploma from Herricks High School in 1998. Brian then attended the University at Buffalo from 1998 to 2002, where they earned a Bachelor of Science degree in Chemistry and Medicinal Chemistry. Tse then went on to attend Harvard University from 2002 to 2008, where they earned a PhD in Organic Chemistry and Chemical Biology.
This person is not in any offices
The Conafay Group
The Conafay Group works with life science companies and organizations to develop and implement government funding and public policy strategies. We also bridge ties to philanthropic, non-‐profit, academic and commercial entities to enhance client outcomes. Working on behalf of our clients, we create and execute dynamic strategies that facilitate: • Non-Dilutive Funding • Health Policy Advocacy • Ally Development • Federal Government Relations • Public-Private Partnerships • Federal Marketing • Coalition Management • Business-to-Business Partnering TCG specializes in representing biomedical technologies and therapeutics before the federal government and associated stakeholders. Our client successes involve for-profit and non-profit entities in areas of funding, research and public policy. We identify and target novel funding opportunities, synergies between client technology and federal/private needs, and policy issues that affect life sciences companies. Our expertise provides our clients an advantage over competitors in the federal and non-federal funding market. Since 2003, our team has helped clients secure nearly $1B in non-dilutive funding and services. Led by Stephen Conafay, TCG is a team of engineers, scientists, and policy experts, as well as former industry executives and federal staff, who offer a wealth of scientific and policy expertise in issues relevant to the life sciences and biotechnology industry. Applying this collective expertise, we have an intimate understanding of the non-dilutive funding landscape, healthcare and innovation policy, federal government needs and priorities, and commercial/institutional partnering opportunities. Our strength lies in putting this knowledge, and our familiarity with the science behind our clients’ technology, to work for our clients. Through our team‐based approach, we are able to deliver fully integrated government relations strategies that enable our clients to achieve greater success.